Proteomic analysis reveals a novel mechanism induced by the leukemic oncogene Tel/PDGFRβ in stem cells: Activation of the interferon response pathways

Stem Cell Research

Volumn 5, Issue 3, 2010, Pages 226-243

  Dobbin, E ^a   Graham, C ^b   Freeburn, R W ^c   Unwin, R D ^d   Griffiths, J R ^d   Pierce, A ^d   Whetton, A D ^d   Wheadon, H ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN P300; STAT1 PROTEIN; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR ETV6;

ANIMAL CELL; ARTICLE; CANCER GENETICS; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENETIC TRANSCRIPTION; INTERFERON PRODUCTION; MASS SPECTROMETRY; MOUSE; MYELOID PROGENITOR CELL; MYELOPROLIFERATIVE DISORDER; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEOMICS;

ANIMALS; INTERFERON REGULATORY FACTORS; INTERFERON-GAMMA; MASS SPECTROMETRY; MICE; MYELOPOIESIS; PROTEOME; PROTO-ONCOGENE PROTEINS C-ETS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STEM CELLS; UP-REGULATION;

EID: 77957677306     PISSN: 18735061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scr.2010.08.001     Document Type: Article

References (52)

1. Akagi T., Ogawa S., Dugas M., Kawamata N., Yamamoto G., Nannya Y., Sanada M., Miller C.W., Yung A., Schnittger S., Haferlach T., Haferlach C., Koeffler H.P. Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype. Haematologica 2008, 94:213-223.
2. Arai H., Maki K., Waga K., Sasaki K., Nakamura Y., Imai Y., Kurokawa M., Hirai H., Mitani K. Functional regulation of TEL by p38-induced phosphorylation. Biochem. Biophy. Res. Commun. 2002, 299:116-125.
3. Baldridge M.T., King K.Y., Boles N.C., Weksberg D.C., Goodell M.A. Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection. Nature 2010, 465:793-797.
4. Cain J.A., Xiang Z., O'Neal J., Kreisel F., Colson A., Luo H., Hennighausen L., Tomasson M.H. Myeloproliferative disease induced by TEL-PDGFRβ displays dynamic range sensitivity to STAT5 gene dosage. Blood 2007, 109:3906-3914.
5. Carroll M., Tomasson M.H., Barker G.F., Golub T.R., Gilliland D.G. The TEL/PDGFβR fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependentsignalingpathways. Proc. Nat. Acad. Sci. U.S.A. 1996, 93:14845-14850.
6. Cohen H., Azriel A., Cohen T., Meraro D., Hashmueli S., Bech-Otschir D., Kraft R., Dubiel W., Levi B.Z. Interaction between interferon consensus sequence-binding protein and COP9/signalsome subunit CSN2 (Trip15). J. Biol. Chem. 2000, 275:39081-39089.
7. Cristea I.M., Gaskell S.J., Whetton A.D. Proteomics techniques and their application to hematology. Blood 2004, 103:3624-3634.
8. Dobbin E., Corrigan P.M., Walsh C.P., Welham M.J., Freeburn R.W., Wheadon H. Tel/PDGFR[beta] inhibits self-renewal and directs myelomonocytic differentiation of ES cells. Leuk. Res. 2008, 32:1554-1556.
9. Dobbin E., Graham C., Corrigan P.M., Thomas K.G., Freeburn R.W., Wheadon H.W. Tel/PDGFRβ induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways. Exp. Hematol. 2009, 37:111-121.
10. Golub T.R., Barker G.F., Lovett M., Gilliland D.G. Fusion of PDGFRβ to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994, 77:307-316.
11. Greenhalgh C.J., Hilton D.J. Negative regulation of cytokine signaling. J. Leuk. Biol. 2001, 70:348-356.
12. Griffiths J.R., Unwin R.D., Evans C.A., Leech S.H., Corfe B.M., Whetton A.D. The application of a hypothesis-driven strategy to the sensitive detection and location of acetylated lysine residues. J. Am. Soc. Mass Spectrom. 2007, 18:1423-1428.
13. Groettrup M., Khan S., Schwarz K., Schmidtke G. Interferon γ inducible exchange of 20S proteosome active site subunits: Why?. Biochimie 2001, 83:367-372.
14. Hanson C.A., Wood L.D., Hiebert S.W. Cellular stress triggers TEL nuclear export via two genetically separable pathways. J. Cell. Biochem. 2008, 104:488-498.
15. Hirasawa R., Shimizu R., Takahashi S., Osawa M., Takayanagi S., Kato Y., Onodera M., Minegishi N., Yamamoto M., Fukao K., Taniguchi H., Nakauchi H., Iwama A. Essential and instructive roles of GATA factors in eosinophil development. J. Exp. Med. 2002, 195:1379-1386.
16. Holtschke T., Löhler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., Lou J., Knobeloch K.P., Gabriele L., Waring J.F., Bachmann M.F., Zinkernagel R.M., Morse H.C., Ozato K., Horak I. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 1996, 87:307-317.
17. Jousset C., Carron C., Boureux A., Quang C.T., Oury C., Dusanter-Fourt I., Charon M., Levin J., Bernard O., Ghysdael J. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein. EMBO J. 1997, 16:69-82.
18. Kan O., Heyworth C.M., Dexter T.M., Maudsley P.J., Cook N., Vallance S.J., Whetton A.D. Interferon-gamma stimulates the survival and influences the development of bipotential granulocyte-macrophage colony-forming cells. Blood 1991, 78:2588-2594.
19. Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M., Old L.J., Schreiber R.D. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Nat. Acad. Sci. U.S.A. 1998, 95:7556-7561.
20. Kempski H.M., Sturt N.T. The TEL-AML1 fusion accompanied by loss of the untranslocated TEL allele in B-precursor acute lymphoblastic leukaemia of childhood. Leuk. Lymphoma 2000, 40:39-47.
21. Kovacic B., Stoiber D., Moriggl R., Weisz E., Ott R.G., Kreibich R., Levy D.E., Beug H., Freissmuth M., Sexl V. STAT1 acts as a tumor promoter for leukemia development. Cancer Cell 2006, 10:77-87.
22. Kovarik P., Stoiber D., Eyers P.A., Menghini R., Neininger A., Gaestel M., Cohen P., Decker T. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN gamma uses a different signaling pathway. Proc. Nat. Acad. Sci. U.S.A. 1999, 96:13956-13961.
23. Krebs D.L., Hilton D.J. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 2001, 19:378-387.
24. Kuwata T., Gongora C., Kanno Y., Sakaguchi K., Tamura T., Kanno T., Basrur V., Martinez R., Appella E., Golub T., Ozato K. Gamma interferon triggers interaction between ICSBP and TEL recruiting the HDAC3 to the interferon-responsive element. Mol. Cell. Biol. 2002, 22:7439-7448.
25. Lesinski G.B., Anghelina M., Zimmerer J., Bakalakos T., Badgwell B., Parihar R., Hu Y., Becknell B., Abood G., Chaudhury A.R., Magro C., Durbin J., Carson W.E. The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J. Clin. Invest. 2003, 112:170-180.
26. Lu D., Nounou R., Beran M., Estey E., Manshouri T., Kantarjian H., Keating M.J., Albitar M. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer 2003, 97:441-449.
27. Maki K., Arai H., Waga K., Sasaki K., Nakamura F., Imai Y., Kurokawa M., Hirai H., Mitani K. Leukemia-related transcriptional factor TEL is negatively regulated through ERK-induced phosphorylation. Mol. Cell. Biol. 2004, 24:3227-3237.
28. Mamane Y., Heylbroeck C., Génin P., Algarté M., Servant M.J., LePage C., DeLuca C., Kwon H., Lin R., Hiscott J. Interferon regulatory factors: the next generation. Gene 1999, 237:1-14.
29. Martinez R., Golub T.R. Transcriptional repression of ID1 by the leukemogenic ETS protein TEL. Blood 2000, 96:453.
30. Metcalf D., Dakic A., Mifsud S., DiRago L., Wu L., Nutt S. Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia. Proc. Nat. Acad. Sci. U.S.A. 2006, 103:1486-1491.
31. Milanovic M., Terszowski G., Struck D., Liesenfeld O., Carstanjen D. IFN Consensus Sequence Binding protein (ICSBP) is critical for eosinophil development. J. Immunol. 2008, 181:5045-5053.
32. Mueller B.U., Pabst T., Osato M., Asou N., Johansen L.M., Minden M.D., Behre G., Hiddemann W., Ito Y., Tenen D.G., Mueller B.U., Pabst T., Osatao M., et al. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 2002, 100:998-1007.
33. Nguyen H.Q., Hoffman L.B., Liebermann D.A. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell 1993, 72:197-209.
34. Paling N.R.D., Wheadon H., Bone H.K., Welham M.J. Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J. Biol. Chem. 2004, 279:48063-48070.
35. Pierce A., Unwin R.D., Evans C.A., Griffiths S., Carney L., Zhang L., Jaworska E., Lee C.F., Blinco D., Okoniewski M.J., Miller C.J., Bitton D.A., Spooncer E., Whetton A.D. Eight-channel iTRAQ enables comparison of the activity of 6 leukaemogenic tyrosine kinases. Mol. Cell. Proteomics 2008, 7:853-863.
36. Poirel H., Oury C., Carron C., Duprez E., Laabi Y., Tsapis A., Romana S.P., Mauchauffe M., Le Coniat M., Berger R., Ghysdael J., Bernard O.A. The TEL gene products: nuclear phosphoproteins with DNA binding properties. Oncogene 1997, 14:349-357.
37. Rivett A.J., Bose S., Brooks P., Broadfoot K.I. Regulation of proteasome complexes by γ interferon and phosphorylation. Biochimie 2001, 83:363-366.
38. Schindler C., Plumlee C. Interferons pen the JAK-STAT pathway. Sem. Cell Dev. Biol. 2008, 19:311-318.
39. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon γ: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004, 75:163-189.
40. Shtivelman E., Lifshitz B., Gale R.P., Canaani E. Fused transcript of Abl and Bcr genes in chronic myelogenous leukemia. Nature 1985, 315:550-554.
41. Tam W.F., Gu T.L., Chen J., Lee B.H., Bullinger L., Fröhling S., Wang A., Monti S., Golub T.R., Gilliland D.G. Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells. Blood 2008, 112:1981-1992.
42. Tamura T., Ozato K. ICSBP/IRF-8: Its regulatory Roles in the development of myeloid cells. J. Interferon Cytokine Res. 2002, 22:145-152.
43. Tefferi A., Gilliland D.G. Oncogenes in myeloproliferative disorders. Cell Cycle 2007, 16:550-566.
44. Tefferi A., Vardiman J.W. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008, 22:14-22.
45. Tomasson M.H., Sternberg D.W., Williams I.R., Carroll M., Cain D., Aster J.C., Ilaria R.L., Van Etten R.A., Gilliland D.G. Fatal myeloproliferation, induced in mice by TEL/PDGFβR expression, depends on PDGFβR tyrosines 579/581. J. Clin. Invest. 2000, 105:423-432.
46. Tournay O., Benezra R. Transcription of the dominant negative helix-loop-helix protein ID1 is regulated by a protein complex containing the immediate early response gene, Egr-1. Mol. Cell. Biol. 1996, 16:2418-2430.
47. Unwin R.D., Pierce A., Watson R.B., Sternberg D.W., Whetton A.D. Quantitative analysis of the proteome in multiple samples using isobaric protein tags enables rapid comparison of changes in transcription and protein levels. Mol. Cell. Proteomics 2005, 4:924-935.
48. Valgeirsdottir S., Paukku K., Silvennoinen O., Heldin C.H., Claesson-Welsh L. Activation of STAT5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF beta-receptor juxtamembrane and kinase insert domains. Oncogene 1998, 16:505-515.
49. Wheadon H., Welham M.J. The coupling of TEL/PDGFβR to distinct functional responses is modulated by the presence of cytokine: involvement of MAP kinases. Blood 2003, 102:1480-1489.
50. Wilbanks A.M., Mahajan S., Frank D.A., Druker B.J., Gilliland D.G., Carroll M. TEL/PDGF[beta]R fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins. Exp. Hematol. 2000, 28:584-593.
51. Williams S.C., Du Y., Schwartz R.C., Weiler S.R., Ortiz M., Keller J.R., Johnson P.F. C/EBPβ is a myeloid-specific activator of cytokines, chemokine, and macrophage-CSF receptor genes. J. Biol. Chem. 1998, 273:13493-13501.
52. Yu C., Cantor A.B., Yang H., Browne C., Wells R.A., Fujiwara Y., Orkin S.H. Deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophilic lineage in vivo. J. Exp. Med. 2002, 195:1387-1395.